Review of article: chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year cardiovascular disease risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial by Peter J. Curtis, PhD, Mike Sampson, MD, John Potter, MD, Ketan Dhatariya, MD, Paul A. Kroon, PhD, Aedin Cassidy, PhD (Diabetes Care 2012;35:226-32)
- PMID: 23481880
- DOI: 10.1016/j.jvn.2012.12.001
Review of article: chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year cardiovascular disease risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial by Peter J. Curtis, PhD, Mike Sampson, MD, John Potter, MD, Ketan Dhatariya, MD, Paul A. Kroon, PhD, Aedin Cassidy, PhD (Diabetes Care 2012;35:226-32)
Comment on
-
Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.Diabetes Care. 2012 Feb;35(2):226-32. doi: 10.2337/dc11-1443. Epub 2012 Jan 16. Diabetes Care. 2012. PMID: 22250063 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources